GLOW vs KLOW: 70mg and 80mg Peptide Blend Comparison

GLOW 70mg and KLOW 80mg differ by one listed component: KLOW adds 10mg of KPV to the GHK-Cu, BPC-157 and TB-500 amounts listed in GLOW. The comparison below describes Vault’s current catalog formulations. Blend names alone do not establish composition, stability or experimental performance.

GLOW vs KLOW: component amounts per vial

These are labeled amounts, not a transcription of a particular batch’s measured results. The 70mg and 80mg totals refer to all listed components combined; neither label means 70mg or 80mg of each peptide. KLOW’s additional 10mg does not establish that it is more effective for an experiment.

For current pricing, availability and specifications, open GLOW Blend 70mg or KLOW Blend 80mg. The peptide blends catalog shows both listings together.

How to compare the batch documents

1. Match the product name and lot identifier to the material being evaluated.
2. Check the sample description, test date and methods in the available batch certificate of analysis.
3. Distinguish labeled fill content from measured content and chromatographic purity. Record each component result separately when the report supplies it.
4. Identify what was not tested. A report supports the measurements it contains; it is not a stability study or evidence of finished-blend performance unless it documents that work.

If a matching report or required result is unavailable, contact support before selecting the material. An ingredient list does not substitute for batch documentation.

Ingredient literature is not finished-blend evidence

Individual compounds have been investigated in defined experimental models. For example, Chang and colleagues’ BPC-157 study examined growth hormone receptor expression in rat tendon fibroblasts. Maquart and colleagues’ GHK-Cu study examined collagen synthesis in fibroblast cultures.

Neither study establishes the behavior of the GLOW or KLOW formulation sold here. Combining ingredients does not, by itself, demonstrate synergy, compatibility, stability or a particular biological outcome. Research conclusions depend on the material, model, controls and endpoints actually tested.

What about GKP70?

GKP70 appeared in an earlier version of this overview, but it is not a current Vault catalog listing. Do not assume that its name identifies either of the formulations above.

Disclaimer: All products referenced in this article are intended for laboratory and research use only. They are not intended for human consumption. By purchasing from Vault Peptides, you acknowledge these products are for research purposes only and agree to comply with all applicable laws and regulations. Vault Peptides does not make any claims regarding efficacy or safety for non-research applications.